DOSTINEX 0.5 mg, tablet 8 tablets
Active ingredients: Cabergoline
Commercialized according to BDPMDispensing in France: Prescription only
Tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOSTINEX 0,5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 8 comprimé(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63313930CIP74900531CIP133400949005314Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CABERGOLINEcomprimé | 0,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.